Sign up to save your podcasts
Or
Share AI in Drug Discovery and Value of Data with GSK's Kim Branson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI in Drug Discovery and Value of Data with GSK's Kim Branson
Today's guest on Cross Validated is Kim Branson, who is the Senior Vice President and Global Head of AI and ML at GSK. GSK is one of the top 10 largest pharmaceuticals and Fortune 500 company.
On this episode, Kim joins Pauline to discuss both traditional ML and generative AI use cases within GSK, why data and data generation are critical assets to any Fortune 500 company, and how Kim thinks AI should be regulated.
Subscribe for new podcasts and email feedback to [email protected].
Follow on Twitter: @paulinebhyang
Views expressed in this podcast are the speaker’s own and do not necessarily represent the position of GSK.
View all episodes
By Pauline Yang
4.6
55 ratings
Today's guest on Cross Validated is Kim Branson, who is the Senior Vice President and Global Head of AI and ML at GSK. GSK is one of the top 10 largest pharmaceuticals and Fortune 500 company.
On this episode, Kim joins Pauline to discuss both traditional ML and generative AI use cases within GSK, why data and data generation are critical assets to any Fortune 500 company, and how Kim thinks AI should be regulated.
Subscribe for new podcasts and email feedback to [email protected].
Follow on Twitter: @paulinebhyang
Views expressed in this podcast are the speaker’s own and do not necessarily represent the position of GSK.